Evidence map›Paper›PMID 32611912›Full record

ReviewThe Indian journal of medical research2020

COVID-19 pandemic from an ophthalmology point of view.

Parul Chawla Gupta, M Praveen Kumar, Jagat Ram

Abstract readReview
In one paragraph

Review in The Indian journal of medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Artificial intelligence technology for myopia challenges: A review.Frontiers in cell and developmental biology · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Commentary: Impact of COVID-19 on ocular surface health.Indian journal of ophthalmology · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Eye: The Hard-hit Victim of COVID-19 Pandemic.Journal of ophthalmic & vision research
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Parul Chawla GuptaDepartment of Ophthalmology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
M Praveen KumarDepartment of Pharmacology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Jagat RamDepartment of Ophthalmology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is caused by a highly contagious RNA virus termed as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ophthalmologists are at high-risk due to their proximity and short working distance at the time of slit-lamp examination. Eye care professionals can be caught unaware because conjunctivitis may be one of the first signs of COVID-19 at presentation, even precluding the emergence of additional symptoms such as dry cough and anosmia. Breath and eye shields as well as N95 masks, should be worn while examining patients with fever, breathlessness, or any history of international travel or travel from any hotspot besides maintaining hand hygiene. All elective surgeries need to be deferred. Adults or children with sudden-onset painful or painless visual loss, or sudden-onset squint, or sudden-onset floaters or severe lid oedema need a referral for urgent care. Patients should be told to discontinue contact lens wear if they have any symptoms of COVID-19. Cornea retrieval should be avoided in confirmed cases and suspects, and long-term preservation medium for storage of corneas should be encouraged. Retinal screening is unnecessary for coronavirus patients taking chloroquine or hydroxychloroquine as the probability of toxic damage to the retina is less due to short-duration of drug therapy. Tele-ophthalmology and artificial intelligence should be preferred for increasing doctor-patient interaction.

Indexed as

OphthalmologyPandemicsConjunctivitisCorneal TransplantationCoronavirus InfectionsCOVID-19HumansInfectious Disease Transmission, Patient-to-ProfessionalOccupational ExposureOccupational HealthPersonal Protective EquipmentPneumonia, ViralPractice Guidelines as TopicRisk FactorsTearsTelemedicineChloroquine - contact lens - coronavirus - eye donation - eye shields - hydroxychloroquine - ophthalmologist

Identifiers

PMID32611912
PMCPMC7530451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.